Journal
FAMILIAL CANCER
Volume 11, Issue 1, Pages 115-121Publisher
SPRINGER
DOI: 10.1007/s10689-011-9485-3
Keywords
Clinical pathology; Genetic testing; Leiomyoma; Papillary renal carcinoma; Renal cancer; Fumarate hydratase
Categories
Ask authors/readers for more resources
Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) is a hereditary condition which typically presents with cutaneous and uterine leiomyomata. Papillary type II renal cell carcinoma and other less common histologic subtypes of renal cancer have been reported in HLRCC. We describe the case of a 31-year-old man in which the pathology review of his renal carcinoma and a positive family history of renal carcinoma allowed for the identification of a pathogenic mutation in the FH gene (c.698G > A;p.R233H) confirming the diagnosis of HLRCC. Recognition of this syndrome allowed for appropriate surveillance as well as identification of at-risk family members. Pathology review is essential for accurate diagnosis of a hereditary cancer syndrome in the setting of familial renal cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available